(Q80518893)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

major depressive disorder

1 reference

Joel Raskin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jimmy Y Xu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Daniel K Kajdasz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

22 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

International Psychogeriatrics

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

309-327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

Early onset of antidepressant action of venlafaxine: pattern analysis in intent-to-treat patients

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Late-onset major depression: clinical and treatment-response variability

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Delayed onset of action of antidepressant drugs? Survey of recent results

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Clinical trials in late-life depression: revisited

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Treatment of major depression in later life: a life cycle perspective

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Efficacy of Duloxetine on Cognition, Depression, and Pain in Elderly Patients With Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Is there a delay in the antidepressant effect? A meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

On brightening up: triggers and trajectories to recovery from depression

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Two-week delay in onset of action of antidepressants: new evidence

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Can the effects of antidepressants be observed in the first two weeks of treatment?

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Time course of depression-symptom improvement during treatment with duloxetine

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

https://api.crossref.org/works/10.1017%2FS1041610207005649

1 reference

7 January 2021

Development and validation of a geriatric depression screening scale: a preliminary report

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Time course of response to antidepressants in late-life major depression: therapeutic implications

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

Placebo control groups in trials of major depressive disorder among older patients

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207005649

7 January 2021

10.1017/S1041610207005649

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17588276%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference